Iowa City, Iowa -University of Iowa Health Care is taking part in the Phase 3 clinical trial for the new Novavax COVID-19 vaccine.
The medical center is enrolling 250 people to test the vaccine for its rate of success and safety.
Participants will get two doses, and one-third of them will receive a placebo in the trial.
University of Iowa Health Care previously took part in the clinical trial for the Pfizer vaccine, which is now being administered across the nation.
Novavax uses a more traditional vaccine technology than the Pfizer and Moderna vaccines, which use mRNA to generate an immune response.
By Sue Danielson
Jan 8, 2021
(Iowa City, IA) University of Iowa Health Care is taking part in COVID-19 vaccine trial. Researchers are testing a vaccine by Novavax. The multi-site clinical trial aims to enroll 30-thousand people, 250-in Iowa. Participants will get two doses of the vaccine, 21-days apart.
“Different types of vaccines are helpful
because certain people might respond better to one type of vaccine than another,” says Patricia Winokur, MD, executive dean of the University of Iowa Carver College of Medicine, and principal investigator for the UI trial site for the Novavax vaccine. Winokur also led the UI site for the clinical trial of the Pfizer-BioNTech vaccine.
By Sue Danielson
Jan 8, 2021
(Iowa City, IA) University of Iowa Health Care is taking part in COVID-19 vaccine trial. Researchers are testing a vaccine by Novavax. The multi-site clinical trial aims to enroll 30-thousand people, 250-in Iowa. Participants will get two doses of the vaccine, 21-days apart.
“Different types of vaccines are helpful
because certain people might respond better to one type of vaccine than another,” says Patricia Winokur, MD, executive dean of the University of Iowa Carver College of Medicine, and principal investigator for the UI trial site for the Novavax vaccine. Winokur also led the UI site for the clinical trial of the Pfizer-BioNTech vaccine.
I m aching for the rest of the community to catch up with us : Nurse practitioner gets COVID booster, completes vaccine series
Allison Wynes, a nurse practitioner at University of Iowa Health Care, still plans to take steps to slow the spread of COVID-19, despite now being fully vaccinated. Author: Rachel Droze Updated: 12:21 AM CST January 6, 2021
IOWA CITY, Iowa
Some Iowans at the highest risk of exposure have now been fully vaccinated for COVID-19.
Allison Wynes, a nurse practitioner at University of Iowa Hospitals & Clinics, said she works directly with COVID patients.
Wynes was the fifth Iowan to get the COVID-19 vaccine in December.
IOWA CITY Although millions of distributed COVID-19 vaccine doses have yet to make it into American arms, University of Iowa Health Care has used every dose it got “within seven days of receiving it,” officials said Wednesday.
UIHC has no plans to extend the reach of its limited vaccine supply by administering just half of the recommended two-dose course to employees as some national experts have suggested in hopes of getting more Americans at least some degree of protection as the virus continues its spread.
“We will continue to provide a second dose to employees in accordance with guidance from the (Food and Drug Administration),” officials said.